ACTIVE

Vifor Fresenius Medical Care Renal Pharma België

Financial year 2025 · Closed on 30/06/2025

Net result39,9 k €-37,2 %over 1 year

Gross margin47,5 k €-25,4 %over 1 year

Equity489,2 k €+8,9 %over 1 year

Identity

Source · BCE/KBO

Vifor Fresenius Medical Care Renal Pharma België is a Public limited company incorporated in 2015. Its main activity is: Wholesale of pharmaceutical goods. Its registered office is in Antwerpen.

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0599.774.853
Incorporation: 27/02/2015
Legal form: Public limited company
Registered office: Uitbreidingstraat 84
2600 Antwerpen · FlandreSee on map
Contributed capital: 61 500,00 €
Latest accounts: 30/06/2025

Activities (NACE)

46460Wholesale of pharmaceutical goods· main 46460Wholesale of pharmaceutical goods

Joint committees (1)

Signals

ProfitableSolid equityLow riskGood liquidityPositive cashflowPositive EBITDA

Financials

Source · NBB, 9 filings

Trend over 8 financial years

	2025		2024		2023		2021		2020
Income statement
Gross margin	47,5 k €	-25.4%	63,6 k €	-41.5%	108,7 k €	+13.0%	96,2 k €	-37.2%	153,3 k €
EBITDA	47,5 k €	-25.4%	63,6 k €	-41.5%	108,7 k €	+13.0%	96,2 k €	-37.2%	153,3 k €
Operating result	47,5 k €	-25.4%	63,6 k €	-41.5%	108,7 k €	+13.0%	96,2 k €	-37.2%	153,3 k €
Net result	39,9 k €	-37.2%	63,6 k €	-16.9%	76,5 k €	+13.7%	67,3 k €	-38.9%	110,2 k €
Balance sheet
Equity	489,2 k €	+8.9%	449,3 k €	+16.5%	385,8 k €	+24.7%	309,3 k €	+27.8%	242 k €
Total assets	621,7 k €	-15.1%	732,3 k €	+54.3%	474,4 k €	-33.3%	711,8 k €	+28.4%	554,1 k €
Cash	–		–		0 €	-100%	0,8 €		–
Debts	132,4 k €	-53.2%	282,9 k €	+219%	88,7 k €	-78.0%	402,5 k €	+28.9%	312,2 k €
Other
Workforce	–		0,0 ETP		0,0 ETP		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 250 k€ and 500 k€

See the valuation

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Theo Nieuwenhuis	Director26/04/2024 → 11/12/2026
Juan Antonio Fernandez De Lassaletta	Director08/12/2023 → 11/12/2026
Marcus Kracht	Director27/02/2015 → 11/12/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Juan Antonio De Lassaletta Fernandez	Director30/06/2023 → 08/12/2023
Andrea Bean	Director09/03/2022 → 12/12/2025
Irwin James	Director01/04/2021 → 09/03/2022

Other companies at this address

Uitbreidingstraat 84 2600 Antwerpen

Company	CBE no.
ACUTUS MEDICAL● Active	0537.488.183
ADHN● Active	0805.644.584
ADVANCED TRAVEL PARTNERS BELGIUM● Active	0477.167.942
Advocatenkantoor Stephanie Verbiest● Active	1009.904.810
AH Connect● Bankrupt	0801.331.153
AJ BUILDINGS● Bankrupt	0784.521.845
akami invest● Active	0779.650.564
AMSAVILLE● Bankrupt	0716.910.271
AMTECCO● Active	0748.398.550
Anesco België● Active	1010.142.261
Anki Technology● Bankrupt	0772.684.281
AOA Management● Active	1034.629.219
Assaleh● Bankrupt	0769.521.982
A.T.P. Services● Active	0424.671.146
Axis Communications Belgium● Active	1004.919.604
BATI CALOR● Active	0790.194.860
BESAFE COMPANY● Bankrupt	0780.454.278
BESPAREN PODEVYN● Bankrupt	0877.582.556
Best Sight Tech● Active	1031.377.937
B&M Building● Bankrupt	0734.889.717

Full financial information

Source · NBB

	2025	2024	2023	2021	2020	2019
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/07/2024	01/07/2023	01/01/2022	01/01/2021	01/01/2020	01/01/2019
Closing of the financial year	30/06/2025	30/06/2024	30/06/2023	31/12/2021	31/12/2020	31/12/2019
Length of the financial year	12 months	12 months	18 months	12 months	12 months	12 months
Filing date	17/12/2025	30/01/2025	22/12/2023	07/07/2022	21/01/2022	14/03/2021
General meeting	12/12/2025	13/12/2024	08/12/2023	30/06/2022	18/01/2022	19/02/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 9 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	30/06/2025	12/12/2025	17/12/2025	Dutch	PDF
Abridged model	30/06/2024	13/12/2024	30/01/2025	Dutch	PDF
Abridged model	30/06/2023	08/12/2023	22/12/2023	Dutch	PDF
Abridged model	31/12/2021	30/06/2022	07/07/2022	Dutch	PDF
Abridged model	31/12/2020	18/01/2022	21/01/2022	Dutch	PDF
Abridged model	31/12/2019	19/02/2021	14/03/2021	Dutch	PDF
Abridged model	31/12/2018	15/06/2020	16/06/2020	Dutch	PDF
Abridged model	31/12/2017	20/12/2019	27/12/2019	Dutch	PDF
Abridged model	31/12/2016	14/06/2019	08/07/2019	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 250 k€ and 500 k€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 30/06/2025

3 active · 7 ended

Active mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Theo Nieuwenhuis	Director26/04/2024 → 11/12/2026
Juan Antonio Fernandez De Lassaletta	Director08/12/2023 → 11/12/2026
Marcus Kracht	Director27/02/2015 → 11/12/2026

Ended mandates

Director	Mandates in this company	Period	Other mandatescurrentendedstruck offbankruptcies
Juan Antonio De Lassaletta Fernandez	Director30/06/2023 → 08/12/2023
Andrea Bean	Director09/03/2022 → 12/12/2025
Irwin James	Director01/04/2021 → 09/03/2022

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Mandates08/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates06/05/2026
ONTSLAGEN - BENOEMINGEN
PDF
Mandates01/10/2025
ONTSLAGEN - BENOEMINGEN
PDF
Mandates17/12/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates09/12/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates11/07/2024
ONTSLAGEN - BENOEMINGEN
PDF
Mandates27/03/2024
ONTSLAGEN - BENOEMINGEN
PDF
Other22/12/2023
DIVERSEN
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

Source · CBE, NBB annual accounts

Year

Identity

Incorporation

Name

Registered office

Annual accounts

Filings8 filings

Mandates

Theo Nieuwenhuis

Juan Antonio Fernandez De Lassaletta

Marcus Kracht

Juan Antonio De Lassaletta Fernandez

Andrea BEAN

Irwin James

Frey Georg

Michel Siegfried

Stefan Schulze

Oliver Kronenberg

201520162017201820192020202120222023202420252026

Vifor Fresenius Medical Care Renal Pharma België

Uitbreidingstraat 84, 2600 Berchem (Antwerp)

Director

CurrentPlanned, not yet servedEndedAccounts filedToday

Registered offices

Source · NBB annual accounts, CBE

Registered address	Period	Source
Uitbreidingstraat 84, 2600 Berchem (Antwerp)Current	accounts 2021 → 2025	Accounts 2025 · 2025-00587727

Company names

Source · NBB annual accounts, CBE

Name	Period	Source
Vifor Fresenius Medical Care Renal Pharma BelgiëCurrent	accounts 2021 → 2025	Accounts 2025 · 2025-00587727

Events

2025
Annual accounts 202539,9 k €↓
2024
Annual accounts 202463,6 k €↓
2023
Annual accounts 202376,5 k €↑
2021
Annual accounts 202167,3 k €↓
2020
Annual accounts 2020110,2 k €↑
2019
Annual accounts 201928,7 k €↑
2018
Annual accounts 20181,1 k €↓
2017
Annual accounts 201716,7 k €
27/02/2015
IncorporationPublic limited company

Vifor Fresenius Medical Care Renal Pharma België

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Other companies at this address

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline

Registered offices

Company names

Events